| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| anti-infectieux cutané |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| agent dépigmentant |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| Pimecrolimus (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| Benzyl benzoate (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| Teniposide (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| Tacalcitol (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Some |
|
| Undecylenic acid and undecylenate salt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing sulconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing terbinafine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Aftershave |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nail cosmetic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nail varnish resin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Pomade |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Ketoconazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely miconazole 25 milligram/1 gram conventional release oral gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin 500000 unit oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin GF/LF/SF 100,000units/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Miconazole nitrate 100 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Miconazole nitrate 100mg/2% pessary+cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin 100,000units pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine diacetate 200 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.02% irrigation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin 100,000units pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.2% mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+chlorbutol 0.1/0.5% mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.2% mint mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Aqueous cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Buffered cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Emulsifying ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hydrous ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hydrous wool fat BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hydrous wool fat ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Simple ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Wool alcohols ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chamomile extracts 10.5% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Unguentum Cocois Co |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hydrous wool fat+zinc oxide 4/8% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Alpha tocopheryl acetate 50iu/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Soap substitute+zinc oxide 5% cream wash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Emollient bath additives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Soya oil+mixed lauromacrogols 82.95/15% bath oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Soya oil 84.75% bath oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Ketoconazole 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Miconazole nitrate 2% dusting powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Sulconazole nitrate 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine 5% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine acetate pink 0.05% irrigation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine obstetric 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 5% concentrated solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine acetate 1% dusting powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate pink 0.05% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.05% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+cetrimide 1.5%/15% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+cetrimide 0.015%/0.15% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Brilliant green+crystal violet 0.5%/0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Crystal violet 0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Methylrosanilinium chloride 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing clioquinol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate solution 1.25% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Miconazole 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+chlorhexidine 1%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+chlorhexidine 2%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS hand rub |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Tolnaftate 10 mg/g cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.02% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate pink 0.5% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate blue 0.5% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]